 is likely a result of
the limited ability of drugs to enhance muscle function or
limb blood ﬂow to the levels observed with therapies such
as exercise training or invasive revascularization.
The beneﬁts of cilostazol in the treatment of IC were
compared with those of pentoxifylline in a randomized
controlled trial (RCT) performed by Dawson et al.96 They
found that cilostazol therapy signiﬁcantly increased maximal